ABOUT US

EYOWN Technologies S.L. is a biotechnology company in Madrid (Tres Cantos) specializing in the optimization of laboratory processes through instrumentation and bioinformatics tools.
Our staff has more than 25 years of experience in the pharmaceutical and biotechnology industry. Through our laboratory of S2B Technology Park of Tres Cantos, we offer our clients different services for the automation of their laboratory processes and the treatment of the generated data; For this we use the most advanced and modern robotic technology connected to our LIMS systems.
  1. A company based in Madrid.
  2. A 100% private company.
  3. Located within the Technology Park of Madrid.
  4. Specialized management team with more than 25 years of experience in the sector.
  5. With a wide range of clients, from the Pharmaceutical Industry to Biotechnology, including Petrochemicals, Renewable Energies and Academic Centers
PrincipitoSlogan2

Antoine de Saint-Exuperry

"To see clearly, it is enough to change the direction of the look."

OUR TEAM

Our team consists of professionals with a double profile, Scientific and Bio-computer.

This mixed training allows us to understand the scientist in his needs and requirements, we speak his own language, and we also treasure own experience in various research areas:

     
  • Drug Discovery
  •  
  • Cytotoxicity
  •  
  • Drug Metabolism
  •  
  • Microbiology
  •  
  • Compound Extraction
  •  
  • Process Quality Control, etc.

MANAGEMENT TEAM

Genoveva Mateos Bugatti

Director and Foundress

Degree in Biology and Master in Biophysics.

Automation Specialist of EYOWN TECHNOLOGIES S.L.

Professional with 11 years of experience in the field of drug discovery, manufacturing, carrying out various types of biochemical and cellular assays, and the automation of laboratory processes in centers such as the National Center for Oncological Research (CNIO) , the pharmaceutical industry (Merck, Sharp & DOHME) and the company MEJORAN LAB AUTOMATION SL

Juan Bautista Crespo García

Director and Founder

Bachelor of Biology specialty Microbiology and Biochemistry. Director and Founder of EYOWN TECHNOLOGIES S.L.

Professional with 26 years of experience in the pharmaceutical industry, drug discovery, manufacturing, data management (LIMS) and laboratory automation.

Director and Founder of MEJORAN LAB AUTOMATION SL, Senior Associate at the Basic Research Center (CIBE), Merck, Sharp & DOHME. Author of 10 publications in international specialized journals.

KEY PEOPLE

Salvador Mateo Cruañas

Business & Marketing Development

More than 30 years of experience in Commercial Support, Technical Assistance and Organizational Management. The last 14 years as a Service Manager for Spain and Portugal in a Swiss company. He completed a Master in Digital Marketing and e-commerce.

Luis Miranda Blanco

Consultant

Degree in Chemistry from the UCM. Consultant in Laboratory Automation of EYOWN TECHNOLOGIES S.L.

ADVISORY SCIENTIFIC COMMITTEE

Miguel Alcalde Galeote

Principal Investigator (ICP-CSIC)  

Dr. Alcalde studied biology at the Complutense University of Madrid, Spain (1988-1993) and in 1994 he obtained a master's degree in plant physiology. In 1999, he completed his doctorate in biochemistry and molecular biology at the Institute of Catalysis (ICP-CSIC, Madrid). From 2001 to 2003, Dr. Mayor took a postdoctoral position at CALTECH under the direction of Prof. Frances H. Arnold. After his return to ICP-Madrid, he was appointed as CSIC staff scientist and promoted to CSIC researcher in 2014. Dr. Alcalde has participated in more than 10 consecutive European projects and several research contracts with industries. Dr. Alcalde is co-author of several patents and more than 100 articles of SCI. Dr. Alcalde is the founder of EvoEnzyme, a derivative of ICP-CSIC (www.evoenzyme.com).

Jose María Sanchez-Puelles

Principal Investigator (CIB-CSIC)

José-María Sánchez-Puelles, 59 years old, Doctor in Biology, Scientific Researcher of the CSIC, directs the group of Molecular Pharmacology in the Department of Molecular Biomedicine of the Center for Biological Research; 36 years of research experience, 22 years in academic institutions. 14 years in R + D + i of the pharmaceutical industry, 12 as Director of R & D in the international area of Drug Discovery at Merck, Sharp & Dohme, SmithKline Beecham and PharmaMar. Member of the International Scientific R & D Committee of these pharmaceutical companies. Author of 46 publications in international journals specialized and responsible for 40 international patents for new compounds and processes. Guest lecturer in public research institutions and private, national and international. Evaluator of the European Commission, Ministry of Education and Science and the Ministry of Industry, member of the Committee Director of European Consortiums as representative of MINECO (ERA-NETs and JPIs). Consultant of pharmaceutical and biotechnology companies (e.g., Genentech, GlaxoSmithKline, MGMis, Best @ n, eYOWN, DOMCA). Founder of two biomedical biotechnology companies, BioSafety and eYOWN

PARTNERS

CUSTOMERS